| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/23/1998 | WO1998004702A3 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use |
| 04/23/1998 | WO1998004686A3 Pro-protein converting enzyme |
| 04/23/1998 | WO1997046585A3 Fragments of leptin (ob protein) |
| 04/23/1998 | WO1997041225A3 Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr] |
| 04/23/1998 | DE19643586A1 Topical sterol formulation for use as deodorant |
| 04/23/1998 | DE19643037A1 Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel New oxadiazoles, processes for their preparation and their use as medicaments |
| 04/23/1998 | CA2505445A1 Fusogenic liposome composition and method |
| 04/23/1998 | CA2323791A1 Purine l-nucleosides, analogs and uses thereof |
| 04/23/1998 | CA2268917A1 New derivates from piperidine-keto acid, their preparation and use |
| 04/23/1998 | CA2268904A1 Diagnosis of spongiform encephalopathy |
| 04/23/1998 | CA2268897A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268895A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268894A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268875A1 Antimicrobial lipids |
| 04/23/1998 | CA2268850A1 Long chain carboxybetaines in antimicrobial formulations |
| 04/23/1998 | CA2268841A1 Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof |
| 04/23/1998 | CA2268823A1 Pyrazolinones to treat disturbances of potency |
| 04/23/1998 | CA2268535A1 Local anesthetic for external use |
| 04/23/1998 | CA2268330A1 8(9)-dehydroestradiol derivatives |
| 04/23/1998 | CA2268103A1 Sulfonamide substituted aspartic acid interleukin-1.beta. converting enzyme inhibitors |
| 04/23/1998 | CA2268098A1 Aspartate ester inhibitors of interleukin-1.beta. converting enzyme |
| 04/23/1998 | CA2268086A1 Sulfonamide interleukin-1.beta. converting enzyme inhibitors |
| 04/23/1998 | CA2267978A1 Method for the prevention of the reinfestation of warm-blooded animals by ectoparasites |
| 04/23/1998 | CA2267320A1 Secondary cataract inhibitor |
| 04/23/1998 | CA2267279A1 Monocyclic l-nucleosides, analogs and uses thereof |
| 04/23/1998 | CA2267173A1 Method for the enhancement of lymphocyte activity against opportunistic microbial pathogens and tumors |
| 04/23/1998 | CA2266889A1 Purine l-nucleosides, analogs and uses thereof |
| 04/23/1998 | CA2249543A1 Simple process for producing high-quality captopril |
| 04/23/1998 | CA2240402A1 Anion exchange resin-containing tablets |
| 04/23/1998 | CA2240328A1 Cervical canal maturing agent |
| 04/22/1998 | EP0837133A2 DNA strand resolution proteins of the resolvase family |
| 04/22/1998 | EP0837130A2 M protein analogue from Streptococcus pneumoniae |
| 04/22/1998 | EP0837069A1 Storage-stabilization method of acarbose |
| 04/22/1998 | EP0837063A1 4-Aminoquinazoline derivatives |
| 04/22/1998 | EP0837061A1 Pharmaceutical acidic compounds |
| 04/22/1998 | EP0837055A1 Substituted Indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them |
| 04/22/1998 | EP0837052A1 Bicyclic amino derivatives and pgd 2 antagonist containing the same |
| 04/22/1998 | EP0836852A1 Use of amlexanox for the manufacture of a medicament for treating aphtous ulcers |
| 04/22/1998 | EP0836851A1 Amidine compounds for use in treating ecto or endo parasitic diseases and systemic parasite control compositions |
| 04/22/1998 | EP0836850A2 Method of preventing allograft rejection |
| 04/22/1998 | EP0836849A2 Pharmaceutical formulations containing gamma amino butyric acid, an anti-oxidant, folic acid, nicotinamide and a lithium salt |
| 04/22/1998 | EP0836648A1 Recombinant mva virus, and the use thereof |
| 04/22/1998 | EP0836645A1 Dry powder formulations of polynucleotide complexes |
| 04/22/1998 | EP0836642A1 Conversion of compactin to pravastatin by actinomadura |
| 04/22/1998 | EP0836621A1 Novel human g-protein coupled receptor |
| 04/22/1998 | EP0836616A1 Macrolides |
| 04/22/1998 | EP0836615A1 New thrombin inhibitors, their preparation and use |
| 04/22/1998 | EP0836613A1 Water-soluble adenosine kinase inhibitors |
| 04/22/1998 | EP0836610A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
| 04/22/1998 | EP0836606A1 Condensed thiazole derivatives, having 5-ht receptor affinity |
| 04/22/1998 | EP0836605A1 Pyrrolopyrimidines and processes for the preparation thereof |
| 04/22/1998 | EP0836604A1 Novel substituted azabicyclic compounds |
| 04/22/1998 | EP0836602A1 Fungicidal pyrimidinones |
| 04/22/1998 | EP0836599A1 1,6-disubstituted isochromans for treatment of migraine headaches |
| 04/22/1998 | EP0836597A1 N-substituted piperazine nonoates |
| 04/22/1998 | EP0836592A1 Azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases |
| 04/22/1998 | EP0836591A1 Semicarbazones having cns activity and pharmaceutical preparations containing same |
| 04/22/1998 | EP0836511A1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 04/22/1998 | EP0836506A1 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| 04/22/1998 | EP0836481A1 Parasitic helminth venom allergen antigen 5-like genes and proteins |
| 04/22/1998 | EP0836480A1 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof |
| 04/22/1998 | EP0836477A1 Antibacterial synergistic composition comprising rifabutin |
| 04/22/1998 | EP0836476A1 A cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders |
| 04/22/1998 | EP0836475A1 Controlled release formulations for poorly soluble drugs |
| 04/22/1998 | EP0836474A1 Method of altering the contents of eggs |
| 04/22/1998 | EP0836472A1 Therapeutic effervescent compositions |
| 04/22/1998 | EP0836445A1 Method for regulating metabolism with dopamine beta hydroxylase inhibitors |
| 04/22/1998 | EP0836383A1 Combinations of inhibitors of farnesyl-protein transferase |
| 04/22/1998 | EP0836382A1 New cryptophycins |
| 04/22/1998 | EP0820285A4 Methods and compositions for lipidization of hydrophilic molecules |
| 04/22/1998 | EP0764027A4 Method for protection against genotoxic mutagenesis |
| 04/22/1998 | EP0746294A4 Absorption enhancers for topical pharmaceutical formulations |
| 04/22/1998 | EP0741686B1 New leukotriene b4 derivatives, methods of preparing them and their use as drugs |
| 04/22/1998 | EP0708755B1 Novel vitamin d analogues |
| 04/22/1998 | EP0708644A4 TREATMENT OF -i(CRYPTOCOCCUS NEOFORMANS) INFECTION |
| 04/22/1998 | EP0703774B1 High foaming oral composition |
| 04/22/1998 | EP0697871A4 Treatment process with biologically active tropane derivatives |
| 04/22/1998 | EP0693080B1 New glucocorticoids |
| 04/22/1998 | EP0686154B1 Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof |
| 04/22/1998 | EP0644891B1 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
| 04/22/1998 | EP0641356B1 Inhibitors of 5-alpha-testosterone reductase |
| 04/22/1998 | EP0631500B1 1 alpha-HYDROXY-24-(EPI)-VITAMIN D4 |
| 04/22/1998 | EP0627913B1 Facilitated oxygen delivery in conjunction with hemodilution |
| 04/22/1998 | EP0618906B1 Substituted imidazole derivatives and their preparation and use |
| 04/22/1998 | EP0607245B1 Cholesterol lowering compounds and process for making them |
| 04/22/1998 | EP0515460B1 Docosahexaenoic acid, methods for its production and compounds containing the same |
| 04/22/1998 | EP0429480B1 Natriuretic hormone |
| 04/22/1998 | CN1179829A Inhibition of tau-tau association |
| 04/22/1998 | CN1179777A Novel taxoids ,preparation thereof, and pharmaceutical compositions containing same |
| 04/22/1998 | CN1179776A Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 04/22/1998 | CN1179775A Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 04/22/1998 | CN1179774A Arginine analogues having nitric oxide synthase inhibitor activity |
| 04/22/1998 | CN1179725A Modulation of cell proliferation and wound healing |
| 04/22/1998 | CN1179724A HCG Liquid formulations |
| 04/22/1998 | CN1179722A Combination therapy for HIV infection using HIV protease inhibitor indinavir and reverse transcriptase inhibitor 3TC, optionally together with AZT, DDI or DDC |
| 04/22/1998 | CN1179721A Novel pharmacetical formulation |
| 04/22/1998 | CN1179720A Corticosteroid-containing pharmaceutical compositions |
| 04/22/1998 | CN1179719A Azathioprine compositions for colonic administration |
| 04/22/1998 | CN1179718A Novel pharmaceutical composition |
| 04/22/1998 | CN1179717A Novel pharmaceutical composition |